Emile Loria
Voorzitter bij Portable Genomics, Inc.
Vermogen: 16 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Emile Loria
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Epimmune, Inc.
5
| Extinct | Pharmaceuticals: Major | 5 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA.
5
| Extinct | Pharmaceuticals: Major | 5 |
Portable Genomics, Inc.
3
| Private Company | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emile Loria via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TRANSGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| TENGION, INC. | Biotechnology | Director/Board Member | |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALZHEON, INC. | Biotechnology | Director/Board Member | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Founder | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Chairman | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree | |
Connecticut Academy of Science & Engineering
 Connecticut Academy of Science & Engineering Miscellaneous Commercial ServicesCommercial Services Connecticut Academy of Science & Engineering engages in the provision of advising state government and industry in the application of science and engineering. It offers studies on public policy issues, general assembly, and private organizations. The company was founded in 1976 and is headquartered in Hartford, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Smithkline Beecham Holdings Corp.
 Smithkline Beecham Holdings Corp. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beecham Holdings Corp. produces and distributes pharmaceutical products and dental healthcare products. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
| European Vaccine Manufacturers | President | ||
| University of Lyon | College/University | Doctorate Degree | |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Penn Presbyterian Medical Center
 Penn Presbyterian Medical Center Hospital/Nursing ManagementHealth Services Penn Presbyterian Medical Center provides health care services. Its services include abdominal imaging, anatomic pathology and breast imaging services. The company as founded in 1871 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Mouvement des Entreprises de France
 Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Mouvement des Entreprises de France operates a network for entrepreneurs. The non-profit company is based in Paris, France. The CEO of the French company is Philippe Pascal Rene Gautier. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France. | Medical Specialties | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| BioVision | Chairman | ||
| Myasterix | Director/Board Member | ||
| Fondation pour l’Université de Lyon | Chairman | ||
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
| Aventis Pharma International SAS | Corporate Officer/Principal | ||
| ALTIMMUNE, INC. | Biotechnology | Director/Board Member | |
| Underground Charity Foundation | Chairman | ||
| Fondation Universite Grenoble Alpes | Director/Board Member | ||
Apie Therapeutics, Inc.
 Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | Medical/Nursing Services | Director/Board Member | |
| The College of Wooster | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 25 |
| Frankrijk | 21 |
| België | 3 |
| Ierland | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 191 |
| Corporate Officer/Principal | 62 |
| Chairman | 52 |
| Independent Dir/Board Member | 38 |
| Chief Executive Officer | 36 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Grey | 32 |
| Magda Marquet | 30 |
| Walter Flamenbaum | 26 |
| Sylvie Grégoire | 25 |
| Didier Hoch | 24 |
| Jean Deleage | 23 |
| Ted Greene | 20 |
| David de Weese | 15 |
| Diane Jorkasky | 15 |
| William T. Comer | 15 |
| Maryvonne Hiance | 15 |
| Guy Chatelain | 13 |
| Robert J. de Vaere | 12 |
| Georges Hibon | 10 |
| Alexis Peyroles | 10 |
- Beurs
- Insiders
- Emile Loria
- Bedrijfsconnecties
